PMID- 20425697 OWN - NLM STAT- MEDLINE DCOM- 20100712 LR - 20220331 IS - 0022-9032 (Print) IS - 0022-9032 (Linking) VI - 68 IP - 4 DP - 2010 Apr TI - Prediction of long-term outcome after primary percutaneous coronary intervention for acute anterior myocardial infarction. PG - 393-400 AB - BACKGROUND: Despite the widespread use of reperfusion methods, the long-term outcome after primary percutaneous coronary intervention (PCI) is variable, and accurate risk stratification is of clinical importance. AIM: To assess the predictors of long term outcome after PCI for acute anterior myocardial infarction (AMI). METHODS: One hundred and twenty-seven consecutive patients undergoing PCI within 12 hours from the onset of the first AMI were enrolled. Troponin I, CK-MB, creatinine, NT-proBNP, echocardiographic left ventricular (LV) function, myocardial contrast perfusion, results of coronary angiography, ECG, 24-hour Holter ECG, and T-wave alternans (TWA) were analysed as predictors of major adverse cardiac events (MACE), defined as death, non-fatal reinfarction, sustained ventricular tachycardia, and rehospitalisation for decompensated heart failure. Patients were followed up for two years. RESULTS: Twenty-seven patients developed MACE. The best predictive model for MACE consisted of impaired perfusion (MCE, myocardial contrast echocardiography), higher CK-MB at 24 hours, discharge NT-proBNP, and non-negative TWA. The combination of elevated creatinine level, decreased LV ejection fraction, and a non-negative TWA proved the best for identification of patients at risk of cardiac death. The best multivariate model for predicting heart failure hospitalisation consisted of higher 24-hour CK-MB, discharge NT-proBNP, impaired perfusion and prolonged duration of ST elevation. CONCLUSIONS: Our study showed that the rate of MACE in patients with anterior ST-segment elevation myocardial infarction undergoing primary PCI at two years follow-up is low. A combined assessment of myocardial contrast perfusion, TWA, CK-MB and discharge NT-proBNP seems to optimally predict patients at risk of MACE. FAU - Wita, Krystian AU - Wita K AD - Department of Cardiology, Medical University of Silesia, Katowice, Poland. FAU - Filipecki, Artur AU - Filipecki A FAU - Szydlo, Krzysztof AU - Szydlo K FAU - Turski, Maciej AU - Turski M FAU - Tabor, Zbigniew AU - Tabor Z FAU - Wrobel, Wojciech AU - Wrobel W FAU - Elzbieciak, Marek AU - Elzbieciak M FAU - Lelek, Michal AU - Lelek M FAU - Bochenek, Tomasz AU - Bochenek T FAU - Trusz-Gluza, Maria AU - Trusz-Gluza M LA - eng PT - Clinical Trial PT - Journal Article PL - Poland TA - Kardiol Pol JT - Kardiologia polska JID - 0376352 SB - IM CIN - Kardiol Pol. 2010 Apr;68(4):401-2. PMID: 20425698 MH - Angiography MH - *Angioplasty, Balloon, Coronary MH - Disease-Free Survival MH - Echocardiography MH - Electrocardiography MH - Female MH - Follow-Up Studies MH - Humans MH - Male MH - Middle Aged MH - Multivariate Analysis MH - Myocardial Infarction/*diagnosis/*therapy MH - Prognosis MH - Prospective Studies MH - Treatment Outcome EDAT- 2010/04/29 06:00 MHDA- 2010/07/14 06:00 CRDT- 2010/04/29 06:00 PHST- 2010/04/29 06:00 [entrez] PHST- 2010/04/29 06:00 [pubmed] PHST- 2010/07/14 06:00 [medline] PST - ppublish SO - Kardiol Pol. 2010 Apr;68(4):393-400.